DEXAMETHASONE SODIUM PHOSPHATE injection, solution United States - English - NLM (National Library of Medicine)

dexamethasone sodium phosphate injection, solution

general injectables & vaccines, inc. - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - a. intravenous or intramuscular administration . when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. endocrine disorders . primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is

Cortexonavet 2 mg/ml inj. sol. i.v./i.artic./i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cortexonavet 2 mg/ml inj. sol. i.v./i.artic./i.m. vial

laboratorios syva s.a. - dexamethasone sodium phosphate 2,63 mg/ml - eq. dexamethasone 2 mg/ml - solution for injection - 2 mg/ml - dexamethasone sodium phosphate 2.63 mg/ml - dexamethasone - cattle; horse; pig; dog; cat

Dexa 0,2% 2 mg/ml inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dexa 0,2% 2 mg/ml inj. sol. i.v. vial

kela sa-nv - dexamethasone sodium phosphate 2,64 mg/ml - solution for injection - 2 mg/ml - dexamethasone sodium phosphate 2.64 mg/ml - dexamethasone - cattle

Dexashot 2 mg/ml inj. sol. i.m./i.v./i.artic. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dexashot 2 mg/ml inj. sol. i.m./i.v./i.artic. vial

vet-agro multi-trade company sp. z o.o. - dexamethasone sodium phosphate 2,63 mg/ml - eq. dexamethasone 2 mg/ml - solution for injection - 2 mg/ml - dexamethasone sodium phosphate 2.63 mg/ml - dexamethasone - cattle; pig; cat; dog; horse

Fordexin 2 mg/ml inj. sol. i.v./i.artic./i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fordexin 2 mg/ml inj. sol. i.v./i.artic./i.m. vial

livisto int'l s.l. - dexamethasone sodium phosphate 2,63 mg/ml - eq. dexamethasone 2 mg/ml - solution for injection - 2 mg/ml - dexamethasone sodium phosphate 2.63 mg/ml - dexamethasone - dog; cat; horse; cattle; pig

DEXAMETHASONE SODIUM PHOSPHATE injection United States - English - NLM (National Library of Medicine)

dexamethasone sodium phosphate injection

civica, inc. - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - a. intravenous or intramuscular administration. when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance) acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used) preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is susp

DEXAMETHASONE SODIUM PHOSPHATE injection, solution United States - English - NLM (National Library of Medicine)

dexamethasone sodium phosphate injection, solution

hf acquisition co llc, dba healthfirst - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - a. intravenous or intramuscular administration. when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. endocrine disorders. primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is sus

DEXAMETHASONE SODIUM PHOSPHATE injection, solution United States - English - NLM (National Library of Medicine)

dexamethasone sodium phosphate injection, solution

medical purchasing solutions, llc - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - a. intravenous or intramuscular administration when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. endocrine disorders. primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is susp

Glucadex 2 mg/ml inj. sol. i.v./i.m./i.artic./p.artic./s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glucadex 2 mg/ml inj. sol. i.v./i.m./i.artic./p.artic./s.c. vial

kepro b.v. - dexamethasone sodium phosphate 2,63 mg/ml - eq. dexamethasone 2 mg/ml - solution for injection - 2 mg/ml - dexamethasone sodium phosphate 2.63 mg/ml - dexamethasone - pig; horse; cattle; dog; cat; goat

DEXAMETHASONE SODIUM PHOSPHATE injection, solution United States - English - NLM (National Library of Medicine)

dexamethasone sodium phosphate injection, solution

asclemed usa, inc. - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - a. by intravenous or intramuscular injection when oral therapy is not feasible: 1. endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected. congenital adrenal hyperplasia. nonsuppurative thyroiditis. hypercalcemia associated with cancer. 2. rheumatic disorders: as adjunctive therapy for short-term administration (to tide the patie